Chengdu
688319.SSChengdu Olymvax Biopharmaceuticals Inc. Price (688319.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
405,440,226
(0.0432)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 498,165 | 83,577 | 419,322 | 161,282 | 14,592,604 | 76,335,196 | 179,114,066 | 320,109,157 | 487,151,580 | 547,480,719 | 496,118,667 |
| Net Income | -23,235,743 | -24,935,421 | -52,354,918 | -55,530,681 | -27,239,861 | -19,006,865 | -31,040,632 | 23,579,540 | 107,963,523 | 26,577,086 | 17,555,561 |
| FCF USD | -59,181,812 | -18,130,704 | -39,874,398 | -49,377,243 | -37,233,420 | -34,807,816 | -70,968,287 | -17,758,841 | -29,745,572 | -225,244,204 | -125,883,946 |
| OCF USD | -19,294,169 | -13,511,914 | -27,039,798 | -42,564,590 | -21,498,383 | -16,695,684 | -41,767,605 | 21,089,134 | 39,961,825 | -24,549,804 | 44,000,769 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | -1.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.03 | 1.47 | 15.88 |
| D/E | 0.30 | 0.33 | 0.00 | 0.00 | 0.00 | 0.10 | 0.01 | 0.07 | 0.05 | 0.15 | 0.26 |
| CA/CL | 2.54 | 0.41 | 1.17 | 0.50 | 1.40 | 0.91 | 1.81 | 1.51 | 2.56 | 1.78 | 1.96 |
| TA/TL | 3.76 | 3.03 | 4.85 | 11.04 | 4.72 | 3.21 | 3.32 | 2.43 | 3.30 | 2.52 | 2.37 |
| Total Debt | 50,000,000 | 47,000,000 | 0 | 0 | 0 | 20,000,000 | 5,000,000 | 25,000,000 | 38,253,793 | 134,034,603 | 237,605,284 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | -12.27% | -14.98% | -25.24% | -30.14% | -13.08% | -9.79% | -6.70% | 7.45% | 11.30% | 4.05% | 0.19% |
| ROE | -13.83% | -17.42% | -25.31% | -30.79% | -12.76% | -9.77% | -9.11% | 6.26% | 12.78% | 3.01% | 1.91% |
| ROA | 0.00% | -11.67% | -19.73% | -27.24% | -10.06% | -6.73% | -6.36% | 5.63% | 8.91% | 1.80% | 0.71% |
| NM % | -4,664.27% | -29,835.27% | -12,485.61% | -34,430.80% | -186.67% | -24.90% | -17.33% | 7.37% | 22.16% | 4.85% | 3.54% |
| FCF / R% | 0.00% | -21,693.41% | -9,509.25% | -30,615.47% | -255.15% | -45.60% | -39.62% | -5.55% | -6.11% | -41.14% | -25.37% |
| FCF / NI% | 254.70% | 72.71% | 76.16% | 88.92% | 136.69% | 183.13% | 228.63% | -49.15% | -27.55% | -847.51% | -1,100.28% |
| Operating Margin (OM) | 0.00 | -848.06 | -342.09 | -1,233.72 | -15.43 | -3.20 | -1.54 | -0.75 | -0.27 | -0.20 | -0.19 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.00 | -0.18 | -0.31 | -0.29 | -0.13 | -0.09 | -0.08 | 0.06 | 0.27 | 0.07 | 0.04 |
| SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.37 | 0.44 | 0.79 | 1.20 | 1.35 | 1.22 |
| OCPS | 0.00 | -0.10 | -0.16 | -0.22 | -0.11 | -0.08 | -0.10 | 0.05 | 0.10 | -0.06 | 0.11 |
| FCPS | 0.00 | -0.13 | -0.24 | -0.26 | -0.18 | -0.17 | -0.18 | -0.04 | -0.07 | -0.56 | -0.31 |
| BVPS | 0.00 | 1.04 | 1.25 | 0.97 | 1.05 | 0.95 | 0.84 | 0.93 | 2.08 | 2.20 | 2.30 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.00 | -0.18 | -0.31 | -0.29 | -0.13 | -0.09 | -0.08 | 0.06 | 0.27 | 0.07 | 0.04 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.37 | 0.44 | 0.79 | 1.20 | 1.35 | 1.22 |
| CAGR-OCPS | 0.00 | -0.10 | -0.16 | -0.22 | -0.11 | -0.08 | -0.10 | 0.05 | 0.10 | -0.06 | 0.11 |
| CAGR-FCPS | 0.00 | -0.13 | -0.24 | -0.26 | -0.18 | -0.17 | -0.18 | -0.04 | -0.07 | -0.56 | -0.31 |
| CAGR-BVPS | 0.00 | 1.04 | 1.25 | 0.97 | 1.05 | 0.95 | 0.84 | 0.93 | 2.08 | 2.20 | 2.30 |